(Total Views: 585)
Posted On: 05/19/2020 3:57:30 PM
Post# of 72440
One key difference. B’s data were before infection whereas Remdesivir’s data were after infection. The VERO cells data would be more significant if B is used as a vaccine. Since Leo said that won’t be the case, I don’t expect people will go to the hospital for a B-IV before they test positive, nor insurance would approve it.
The upcoming data on human lung cells after infection are more meaningful for B as a potential treatment. The following PDF file gives you an idea of how B’s after infection data would compare to Remdesivir (starting on page 14, courtesy of KarinCA).
https://www.ema.europa.eu/en/documents/other/...ead_en.pdf
The upcoming data on human lung cells after infection are more meaningful for B as a potential treatment. The following PDF file gives you an idea of how B’s after infection data would compare to Remdesivir (starting on page 14, courtesy of KarinCA).
https://www.ema.europa.eu/en/documents/other/...ead_en.pdf
(0)
(0)
Scroll down for more posts ▼
